Hans-Christian Thorsen-Meyer

Hans-Christian Thorsen-Meyer

Auto-generated profile, based on publicly available information

Hans-Christian Thorsen-Meyer

NNF Center for Protein Research, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2019 in JAMA
Verified
Journal Article
Open access
PDF file
PLPierre-Francois Laterre
Pierre-Francois Laterre
SBScott M. Berry
Scott M. Berry
ABAllan Blemings
Allan Blemings
JCJan E. Carlsen
Jan E. Carlsen
BFBruno François
Bruno François
FIfor the SEPSIS-ACT Investigators
for the SEPSIS-ACT Investigators
Sepsis is a dysregulated host response to infection that leads to life-threatening acute organ dysfunction. Septic shock is the most severe form, characterized by vasodilatation and increased capillary permeability leading to hypotension and tissue hypoxia.1,2 Treatment includes antibiotics and resuscitation with intravenous fluids, vasopressors, and organ support. Even with prompt care, many patients develop multiple organ failure and death.1,2 The recommended first-line vasopressor is the catecholamine, norepinephrine.3 Norepinephrine is not always effective at restoring blood pressure and can cause myocardial and peripheral ischemia.4 Consequently, there is interest in alternative vasopressors, including noncatecholaminergic agents.

1 June 2019 in The Lancet Digital Health
Verified
Journal Article
Open access
ANAnnelaura B Nielsen
Annelaura B Nielsen
HTHans-Christian Thorsen-Meyer
Hans-Christian Thorsen-Meyer
KBKirstine Belling
Kirstine Belling
ANAnna P Nielsen
Anna P Nielsen
CTCecilia E Thomas
Cecilia E Thomas
SBSøren Brunak
Søren Brunak
Intensive-care units (ICUs) treat the most critically ill patients, which is complicated by the heterogeneity of the diseases that they encounter. Severity scores based mainly on acute physiology measures collected at ICU admission are used to predict mortality, but are non-specific, and predictions for individual patients can be inaccurate. We investigated whether inclusion of long-term disease history before ICU admission improves mortality predictions. Registry data for long-term disease histories for more than 230 000 Danish ICU patients were used in a neural network to develop an ICU mortality prediction model. Long-term disease histories and acute physiology measures were aggregated to predict mortality risk for patients for whom both registry and ICU electronic patient record data were available. We compared mortality predictions with admission scores on the Simplified Acute Physiology Score (SAPS) II, the Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II, and the best available multimorbidity score, the Multimorbidity Index. An external validation set from an additional hospital was acquired after model construction to confirm the validity of our model. During initial model development data were split into a training set (85%) and an independent test set (15%), and a five-fold cross-validation was done during training to avoid overfitting. Neural networks were trained for datasets with disease history of 1 month, 3 months, 6 months, 1 year, 2·5 years, 5 years, 7·5 years, 10 years, and 23 years before ICU admission. Mortality predictions with a model based solely on disease history outperformed the Multimorbidity Index (Matthews correlation coefficient 0·265 vs 0·065), and performed similarly to SAPS II and APACHE II (Matthews correlation coefficient with disease history, age, and sex 0·326 vs 0·347 and 0·300 for SAPS II and APACHE II, respectively). Diagnoses up to 10 years before ICU admission affected current mortality prediction. Aggregation of previous disease history and acute physiology measures in a neural network yielded the most precise predictions of in-hospital mortality (Matthews correlation coefficient 0·391 for in-hospital mortality compared with 0·347 with SAPS II and 0·300 with APACHE II). These results for the aggregated model were validated in an external independent dataset of 1528 patients (Matthews correlation coefficient for prediction of in-hospital mortality 0·341). Longitudinal disease-spectrum-wide data available before ICU admission are useful for mortality prediction. Disease history can be used to differentiate mortality risk between patients with similar vital signs with more precision than SAPS II and APACHE II scores. Machine learning models can be deconvoluted to generate novel understandings of how ICU patient features from long-term and short-term events interact with each other. Explainable machine learning models are key in clinical settings, and our results emphasise how to progress towards the transformation of advanced models into actionable, transparent, and trustworthy clinical tools. Novo Nordisk Foundation and Innovation Fund Denmark.

31 December 2012 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
COC. Ovesen
C. Ovesen
MBM. Brizzi
M. Brizzi
FPF. C. Pott
F. C. Pott
HTH. C. Thorsen-Meyer
H. C. Thorsen-Meyer
TKT. Karlsson
T. Karlsson
JPJ. Petersson
J. Petersson
Background Therapeutic hypothermia (TH) is a promising treatment of stroke, but limited data are available regarding the safety and effectiveness of cooling methodology. We investigated the safety of TH and compared the cooling capacity of two widely used cooling strategies – endovascular and surface cooling. Methods COOLAID Oresund is a bicentre randomized trial in Copenhagen (Denmark) and Malmö (Sweden). Patients were randomized to either TH (33°C for 24 h) in a general intensive care unit (ICU) or standardized stroke unit care (control). Cooling was induced by a surface or endovascular‐based strategy. Results Thirty‐one patients were randomized. Seven were cooled using endovascular and 10 using surface‐based cooling methods and 14 patients received standard care (controls). 14 (45%) patients received thrombolysis. Pneumonia was recorded in 6 (35%) TH patients and in 1 (7%) control. 4 TH patients and 1 control developed massive infarction. 1 TH patient and 2 control suffered asymptomatic haemorrhagic transformation. Mortality was comparable with 2 (12%) in the TH group and 1 (7%) among controls. Mean (SD) duration of hospital stay was 25.0 days (24, 9) in TH and 22.5 days (20.6) in control patients (P = 0.767). Mean (SD) induction period (cooling onset to target temperature) was 126.3 min (80.6) with endovascular cooling and 196.3 min (76.3) with surface cooling (P = 0.025). Conclusions Therapeutic hypothermia with general anaesthesia is feasible in stroke patients. We noticed increased rates of pneumonia, while the length of hospital stay remained comparable. The endovascular cooling strategy provides a faster induction period than surface cooling.

14 January 2020 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
AGAnders Granholm
Anders Granholm
SMSøren Marker
Søren Marker
MKMette Krag
Mette Krag
FZFernando G. Zampieri
Fernando G. Zampieri
HTHans-Christian Thorsen-Meyer
Hans-Christian Thorsen-Meyer
MMMorten Hylander Møller
Morten Hylander Møller

20 April 2023 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
GVGitte K. Vesterlund
Gitte K. Vesterlund
HTHans‐Christian Thorsen‐Meyer
Hans‐Christian Thorsen‐Meyer
MMMorten H. Møller
Morten H. Møller
SBSøren Brunak
Søren Brunak
TSThomas Strøm
Thomas Strøm
BKBenjamin Skov Kaas-Hansen
Benjamin Skov Kaas-Hansen
Background: Abnormal serum levels of magnesium, phosphate, and zinc appear common in intensive care unit (ICU) patients, but the epidemiology, management, and associations with outcomes are less well described. We described these factors and estimated associations with outcomes in a large dataset of Danish ICU patients.Methods: We included adults who were acutely admitted to 10 general ICUs in Denmark between October 2011 and January 2018. From the dataset, we obtained characteristics of patients who had serum levels measured of magnesium, phosphate, or zinc, including data on supplementation. We used joint models with death as a competing outcome to estimate the associations between abnormal serum levels and time to successful extubation and, for magnesium, also incident tachyarrhythmia.Results: We included 16,517 of 36,514 patients in the dataset. The cumulative probability of hypomagnesemia within 28 days was 64% (95% confidence interval [CI] 62–66); of hypophosphatemia 74% (95% CI 72–75); and of hypozincemia 98% (95% CI 98–98). Supplementation of magnesium was used in 3554 out of 13,506 (26%) patients, phosphate in 2115 out of 14,148 (15%) patients, and zinc in 4465 out of 9869 (45%) patients. During ICU stay, 38% experienced hypermagnesemia, 58% hyperphosphatemia, and 1% hyperzincemia. Low serum levels of magnesium, phosphate, and zinc were associated with shorter time to successful extubation, and high serum magnesium and phosphate and low serum zinc with the competing risk of increased mortality, but too few serum measurements made the results inconclusive.Conclusion: In this multicenter cohort study of acutely admitted ICU patients, most experienced low serum levels of magnesium, phosphate, or zinc during ICU stay, many received supplementation, and experiencing both low and high serum levels during ICU stay was not uncommon. Associations between serum levels and clinical outcomes appeared inconclusive because the data proved unfit for these analyses.

28 August 2007 in Research in Sports Medicine
Verified
Journal Article
Closed access
HTHans-Christian M. Thorsen
Hans-Christian M. Thorsen
GZGustavo Zubieta-Calleja
Gustavo Zubieta-Calleja
PPPoul-Erik Paulev
Poul-Erik Paulev
Since the 1960s there have been several reports of divers suffering from decompression sickness (DCS) after repetitive breath-hold (BH) diving. In the period from 1995 to 2000 John Batle observed apparent DCS in 30 free divers competing with underwater scooters in the sea around Mallorca. The cases were treated successfully with recompression therapy. Two of the typical diving profiles, described by Batle, have been submitted to calculations with a modified Haldane model: a perfusion limited, symmetrical multitissue/multilevel model. The model predicts that the two dive profiles will lead to DCS as recorded. A third profile, confirmed by reports to avoid DCS, also were accurately predicted. In order to protect free divers, John Batle developed a dive table for repeated BH diving. According to our calculations the Batle table does not prevent DCS during prolonged exposures. A alternative range of tables is developed and presented.